Ben Gil Price, Director at AVI BIOPHARMA INC (AVII), bought 30,000 shares at $1.30 ($39K) on 2012-03-14, disclosed to the SEC on 2012-03-15.
Open-market purchase of $39k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SRPT | BUY | 2013-08-20 | $16K | — | Filing → |
| AVII | BUY | 2011-04-06 | $30K | — | Filing → |
| AVII | BUY | 2010-08-16 | $8K | — | Filing → |